Loading clinical trials...
Loading clinical trials...
PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients Assessment of the Correlation Between Body Mass Index and Recurrence Among Zoladex Treated Prostate Cancer Patients
Conditions
Locations
34
Hungary
Research Site
Baja, Hungary
Research Site
Barcs, Hungary
Research Site
Békés, Hungary
Research Site
Békéscsaba, Hungary
Research Site
Budapest, Hungary
Research Site
Csongrád, Hungary
Start Date
November 1, 2009
Primary Completion Date
March 1, 2013
Completion Date
March 1, 2013
Last Updated
April 30, 2013
NCT01143454
NCT07472881
NCT06842498
NCT04550494
NCT05691465
NCT03594760
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions